Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：50

作者：

Baekelandt, M. M. ^{[1
]}

Castiglione, M. ^{[2
]}

机构：

[1] Norwegian Radium Hosp, Dept Gynecol Oncol, Oslo, Norway

[2] Univ Geneva, Inst Social & Prevent Med, Geneva, Switzerland

来源：

ANNALS OF ONCOLOGY | 2009年 / 20卷

关键词：

GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-III TRIAL; UTERINE-CANCER; RADIOTHERAPY; DOXORUBICIN; CISPLATIN; LYMPHADENECTOMY; WOMEN;

D O I：

10.1093/annonc/mdp120

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：29 / 31

页数：3

共 13 条

[1]

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group [J].

Aapro, MS ;

van Wijk, FH ;

Bolis, G ;

Chevallier, B ;

van der Burg, MEL ;

Poveda, A ;

de Oliveira, CF ;

Tumolo, S ;

di Palumbo, VS ;

Piccart, M ;

Franchi, M ;

Zanaboni, F ;

Lacave, AJ ;

Fontanelli, R ;

Favalli, G ;

Zola, P ;

Guastalla, JP ;

Rosso, R ;

Marth, C ;

Nooij, M ;

Presti, M ;

Scarabelli, C ;

Splinter, TAW ;

Ploch, E ;

Beex, LVA ;

Huinink, WT ;

Forni, M ;

Melpignano, M ;

Blake, P ;

Kerbrat, P ;

Mendiola, C ;

Cervantes, A ;

Goupil, A ;

Harper, PG ;

Madronal, C ;

Namer, M ;

Scarfone, G ;

Stoot, JEGM ;

Teodorovic, I ;

Coens, C ;

Vergote, I ;

Vermorken, JB .

ANNALS OF ONCOLOGY, 2003, 14 (03) :441-448

[2]

[Anonymous], 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001040

[3]

The outcomes of 27,063 women with unstaged endometrioid uterine cancer [J].

Chan, John K. ;

Wu, Huahsi ;

Cheung, Michael K. ;

Shin, Jacob Y. ;

Osann, Kathryn ;

Kapp, Daniel S. .

GYNECOLOGIC ONCOLOGY, 2007, 106 (02) :282-288

[4]

Lymphadenectomy in endometrioid uterine cancer staging - How many lymph nodes are enough? A study of 11,443 patients [J].

Chan, John K. ;

Urban, Renata ;

Cheung, Michael K. ;

Shin, Jacob Y. ;

Husain, Amreen ;

Teng, Nelson N. ;

Berek, Jonathan S. ;

Walker, Joan L. ;

Kapp, Daniel S. ;

Osann, Kathryn .

CANCER, 2007, 109 (12) :2454-2460

[5]

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study [J].

Fleming, GF ;

Brurietto, VL ;

Cella, D ;

Look, KY ;

Reid, GCH ;

Munkarah, AR ;

Kline, R ;

Burger, RA ;

Goodman, A ;

Burks, RT .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2159-2166

[6]

Predictors of final histology in patients with endometrial cancer [J].

Frumovitz, M ;

Singh, DK ;

Meyer, L ;

Smith, DH ;

Wertheim, I ;

Resnik, E ;

Bodurka, DC .

GYNECOLOGIC ONCOLOGY, 2004, 95 (03) :463-468

[7]

HOGBERG T, 2007, J CLIN ONCOL, V25

[8]

Radiologic staging in patients with endometrial cancer: A meta-analysis [J].

Kinkel, K ;

Kaji, Y ;

Yu, KK ;

Segal, MR ;

Lu, Y ;

Powell, CB ;

Hricak, H .

RADIOLOGY, 1999, 212 (03) :711-718

[9]

Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma:: a study of morbidity and survival [J].

Lambrou, NC ;

Gómez-Marín, O ;

Mirhashemi, R ;

Beach, H ;

Saloma, E ;

Almeida-Parra, Z ;

Peñalver, M .

GYNECOLOGIC ONCOLOGY, 2004, 93 (03) :653-658

[10]

Adjuvant radiotherapy in women with stage I endometrial cancer: A systematic review [J].

Lukka, Himu ;

Chambers, Alexandra ;

Fyles, Anthony ;

Thephamongkhol, Kullathom ;

Fung-Kee-Fung, Michael ;

Elit, Laurie ;

Kwon, Janice .

GYNECOLOGIC ONCOLOGY, 2006, 102 (02) :361-368

← 1 2 →